SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Instruments Regulatory News (OXIG)

Share Price Information for Oxford Instruments (OXIG)

Share Price is delayed by 15 minutes
Get Live Data
2,878.00    130.00 (4.73%)
Bid:
2,846.00
Ask:
2,862.00
Spread: 16.00 (0.562%)
Market Cap: £1.59b
OXIG Live PriceLast checked at - London Stock Exchange

Intraday Oxford Instruments Share Chart

Acquisition

1 May 2015 07:00

RNS Number : 9497L
Oxford Instruments PLC
01 May 2015
 



 

Release date: 1 May 2015

 

Oxford Instruments plc

Acquisition of Medical Imaging Resources, Inc.

 

Oxford Instruments plc, a leading provider of high technology tools and systems for industry and research, today announces the acquisition of Medical Imaging Resources, Inc. (MIR).

 

Founded in 1990 in Ann Arbor Michigan by CEO John Vartanian, MIR specialises in the build, lease and service of mobile medical imaging labs ("mobiles").

 

The mobile labs are built in MIR's factory, with Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) systems from Siemens, GE, Philips and Toshiba. These are leased to customers across the USA. MIR is also responsible for servicing its mobiles. Customers include hospitals and clinics that need additional capacity or that wish to trial MRI or CT machines without committing to the infrastructure and cost associated with a permanent unit.

 

MIR will form a part of OIHealthcare, within the Group's Service sector, which already services GE MRI and CT machines in the USA. There are a number of synergies with OIHealthcare:

 

· This will be a significant step to making OIHealthcare a multi-skilled independent service provider able to support large individual service contracts;

· Access to OIHealthcare's parts and its purchasing power for complete systems will lower MIR's operating costs;

· There will be overheads savings in those areas where duplication is eliminated;

· MIR currently sub-contracts a significant portion of the service work for its mobiles. OIHealthcare staff are located in numerous states and once trained will take over the work and will be able to bring the margin in-house.

 

Consideration, which will be satisfied from existing facilities, comprises $10.4 million (c. £6.8 million) on completion followed by a further $10.1 million (c. £6.6 million) earn-out payable one year later. MIR has approximately $3.0 million (c. £2.0 million) net debt at completion.

 

In the year to 31 December 2014, MIR had sales of $16.6 million (c. £10.8 million), profit before tax of $2.8 million (c. £1.8 million) and EBITDA of $5.6 million (c. £3.6 million). At 31 December 2014, MIR had gross assets of $9.4 million (c. £6.1 million).

 

 

 

Jonathan Flint (Chief Executive) and Kevin Boyd (Finance Director) will host a conference call for analysts and investors on this announcement at 9:30 am (UK time), today 1 May. To join the call, please use the dial-in numbers below:

 

Dial: +44 (0)20 3139 4830

PIN: 89662683#

 

 

 

- Ends -

 

Enquiries:

 

 

Oxford Instruments plc Tel: 01865 393200

Jonathan Flint, Chief Executive

Kevin Boyd, Group Finance Director

 

MHP Tel: 020 3128 8100

Rachel Hirst / Jack Holden

 

Issued for and on behalf of Oxford Instruments plc

 

 

 

Notes to Editors  

 

About Oxford Instruments plc

Oxford Instruments designs, supplies and supports high-technology tools and systems with a focus on research and industrial applications. Innovation has been the driving force behind Oxford Instruments' growth and success for over 50 years, and its strategy is to effect the successful commercialisation of these ideas by bringing them to market in a timely and customer-focused fashion.

The first technology business to be spun out from Oxford University, Oxford Instruments objective is to be the leading provider of new generation tools and systems for the research and industrial sectors with a focus on nanotechnology. Its key market sectors include nano-fabrication and nano-materials. The company's strategy is to expand the business into the life sciences arena, where nanotechnology and biotechnology intersect.

This involves the combination of core technologies in areas such as low temperature, high magnetic field and ultra high vacuum environments; Nuclear Magnetic Resonance; x-ray, electron, laser and optical based metrology; atomic force microscopy; optical imaging; advanced growth, deposition and etching.

Oxford Instruments aims to pursue responsible development and deeper understanding of our world through science and technology. Its products, expertise, and ideas address global issues such as energy, environment, security and health.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQEAFLEDSDSEAF
Date   Source Headline
14th Sep 20159:59 amPRNDirector/PDMR Shareholding
8th Sep 20155:32 pmPRNResult of AGM
8th Sep 20157:00 amRNSAGM Statement
1st Sep 201510:03 amPRNTotal Voting Rights
11th Aug 20153:34 pmPRNDirector/PDMR Shareholding
6th Aug 20158:51 amPRNHolding(s) in Company
24th Jul 201512:47 pmPRNDirector/PDMR Shareholding
6th Jul 201511:58 amPRNTotal Voting Rights
23rd Jun 20154:42 pmPRNDirector/PDMR Shareholding
15th Jun 20152:40 pmPRNDirector/PDMR Shareholding
12th Jun 201510:08 amPRNDirector/PDMR Shareholding
9th Jun 20157:00 amRNSFinal Results
28th May 20157:00 amRNSNotice of Results
28th May 20157:00 amRNSJV for Oxford Instruments' Omicron business
21st May 20153:42 pmPRNHolding(s) in Company
13th May 201511:23 amPRNDirector/PDMR Shareholding
11th May 201511:45 amPRNDirector/PDMR Shareholding
1st May 20157:00 amRNSAcquisition
15th Apr 20151:45 pmPRNHolding(s) in Company
15th Apr 20157:00 amRNSTrading Statement
14th Apr 20151:03 pmPRNDirector/PDMR Shareholding
18th Mar 201512:20 pmPRNHolding(s) in Company
12th Mar 20153:12 pmPRNDirector/PDMR Shareholding
2nd Mar 20157:00 amRNSAmendment to existing bank facilities
12th Feb 20159:35 amPRNDirector/PDMR Shareholding
2nd Feb 201510:03 amPRNHolding(s) in Company
28th Jan 20152:26 pmPRNHolding(s) in Company
26th Jan 20153:59 pmPRNHolding(s) in Company
22nd Jan 20157:00 amRNSTrading Statement
20th Jan 20154:51 pmPRNHolding(s) in Company
15th Jan 201511:28 amPRNHolding(s) in Company
15th Jan 201511:06 amPRNDirector/PDMR Shareholding
6th Jan 201510:53 amPRNBlocklisting - Interim Review
6th Jan 201510:40 amPRNTotal Voting Rights
23rd Dec 201410:35 amPRNHolding(s) in Company
12th Dec 20149:34 amPRNDirector/PDMR Shareholding
8th Dec 201411:21 amPRNTotal Voting Rights
3rd Dec 201411:32 amPRNAdditional Listing
19th Nov 20149:24 amPRNHolding(s) in Company
18th Nov 20142:11 pmPRNAdditional Listing
13th Nov 20149:44 amPRNHolding(s) in Company
12th Nov 20141:33 pmPRNHolding(s) in Company
11th Nov 20143:49 pmPRNDirector/PDMR Shareholding
11th Nov 20149:51 amPRNHolding(s) in Company
11th Nov 20147:00 amRNSHalf Yearly Report
4th Nov 20149:10 amPRNTotal Voting Rights
20th Oct 20149:42 amPRNDirector/PDMR Shareholding
10th Oct 20143:17 pmPRNDirector/PDMR Shareholding
7th Oct 20149:12 amPRNTotal Voting Rights
6th Oct 201410:15 amRNSNotice of Half Year Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.